» Articles » PMID: 28332151

Blockade of Neuroglobin Reduces Protection of Conditioned Medium from Human Mesenchymal Stem Cells in Human Astrocyte Model (T98G) Under a Scratch Assay

Overview
Journal Mol Neurobiol
Date 2017 Mar 24
PMID 28332151
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have indicated that paracrine factors (conditioned medium) increase wound closure and reduce reactive oxygen species in a traumatic brain injury in vitro model. Although the beneficial effects of conditioned medium from human adipose tissue-derived mesenchymal stem cells (hMSCA-CM) have been previously suggested for various neurological diseases, their actions on astrocytic cells are not well understood. In this study, we have explored the effect of hMSCA-CM on human astrocyte model (T98G cells) subjected to scratch assay. Our results indicated that hMSCA-CM improved cell viability, reduced nuclear fragmentation, attenuated the production of reactive oxygen species, and preserved mitochondrial membrane potential and ultrastructural parameters. In addition, hMSCA-CM upregulated neuroglobin in T98G cells and the genetic silencing of this protein prevented the protective action of hMSCA-CM on damaged cells, suggesting that neuroglobin is mediating, at least in part, the protective effect of hMSCA-CM. Overall, this evidence suggests that the use of hMSCA-CM is a promising therapeutic strategy for the protection of astrocytic cells in central nervous system (CNS) pathologies.

Citing Articles

Raloxifene Protects Oxygen-Glucose-Deprived Astrocyte Cells Used to Mimic Hypoxic-Ischemic Brain Injury.

Toro-Urrego N, Luaces J, Kobiec T, Udovin L, Bordet S, Otero-Losada M Int J Mol Sci. 2024; 25(22).

PMID: 39596189 PMC: 11594051. DOI: 10.3390/ijms252212121.


Specific nanoprobe design for MRI: Targeting laminin in the blood-brain barrier to follow alteration due to neuroinflammation.

Zapata-Acevedo J, Losada-Barragan M, Osma J, Cruz J, Reiber A, Petry K PLoS One. 2024; 19(4):e0302031.

PMID: 38603692 PMC: 11008835. DOI: 10.1371/journal.pone.0302031.


Secretome as a Tool to Treat Neurological Conditions: Are We Ready?.

da Silva A, Serrenho I, Araujo B, Carvalho A, Baltazar G Int J Mol Sci. 2023; 24(22).

PMID: 38003733 PMC: 10671352. DOI: 10.3390/ijms242216544.


Repurposing of Tibolone in Alzheimer's Disease.

Barreto G Biomolecules. 2023; 13(7).

PMID: 37509151 PMC: 10377087. DOI: 10.3390/biom13071115.


The prognostic value of neutrophil-to-lymphocyte ratio in patients with traumatic brain injury: A systematic review.

Ghozy S, El-Qushayri A, Varney J, Oussama Kacimi S, Bahbah E, Morra M Front Neurol. 2022; 13:1021877.

PMID: 36353130 PMC: 9638118. DOI: 10.3389/fneur.2022.1021877.


References
1.
Wei X, Yang X, Han Z, Qu F, Shao L, Shi Y . Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013; 34(6):747-54. PMC: 4002895. DOI: 10.1038/aps.2013.50. View

2.
Toma C, Pittenger M, Cahill K, Byrne B, Kessler P . Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002; 105(1):93-8. DOI: 10.1161/hc0102.101442. View

3.
Guerit D, Brondello J, Chuchana P, Philipot D, Toupet K, Bony C . FOXO3A regulation by miRNA-29a Controls chondrogenic differentiation of mesenchymal stem cells and cartilage formation. Stem Cells Dev. 2014; 23(11):1195-205. DOI: 10.1089/scd.2013.0463. View

4.
Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, Bornhauser M . Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 2004; 22(3):377-84. DOI: 10.1634/stemcells.22-3-377. View

5.
Gnecchi M, Danieli P, Malpasso G, Ciuffreda M . Paracrine Mechanisms of Mesenchymal Stem Cells in Tissue Repair. Methods Mol Biol. 2016; 1416:123-46. DOI: 10.1007/978-1-4939-3584-0_7. View